Your browser doesn't support javascript.
loading
Aromatase inhibitor-induced arthralgia ameliorated by Mediterranean diet and active lifestyle guided by continuous glucose monitoring: a case report and review of the literature.
Wilson, Kalin L; Grewelle, Richard E; Gupta, Tanya; Kim, Sun H; Katsumoto, Tamiko R.
Afiliação
  • Wilson KL; Department of Medicine, Stanford University School of Medicine, Stanford, CA, United States.
  • Grewelle RE; Department of Biology, Stanford University, Stanford, CA, United States.
  • Gupta T; Department of Genetics, Stanford University School of Medicine, Stanford, CA, United States.
  • Kim SH; Department of Medicine, Division of Oncology, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, United States.
  • Katsumoto TR; Department of Medicine, Division of Endocrinology, Stanford University School of Medicine, Stanford, CA, United States.
Front Oncol ; 14: 1189287, 2024.
Article em En | MEDLINE | ID: mdl-38361780
ABSTRACT
Aromatase inhibitors (AIs) are a cornerstone adjuvant treatment of many hormone receptor-positive breast cancers, and nearly half of women taking aromatase inhibitors suffer from AI-induced arthralgia (AIA), also known as AI-associated musculoskeletal syndrome (AIMSS), for which there are limited evidence-based treatments. Pharmacologic management and complementary methods including supplements, exercise, physical therapy, yoga, acupuncture, and massage have all shown mixed results. Comprehensive diet and lifestyle strategies are understudied in AIA/AIMSS despite their disease-modifying effects across many chronic conditions. Here we report a case of a woman with stage 2 estrogen and progesterone receptor-positive invasive ductal carcinoma on adjuvant anastrozole whose AI-induced arthralgia was durably controlled through a Mediterranean plant-forward diet and daily physical activity guided by continuous glucose monitoring. We posit that diet and a lifestyle inclusive of daily physical activity constitute a low-cost, low-risk, and potentially high-reward strategy for controlling common AI-induced musculoskeletal symptoms and that more investigation in this arena, including well-designed randomized trials, is warranted.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2024 Tipo de documento: Article